Allergan CEO says better to leave discoveries to others
 

Allergan CEO says better to leave discoveries to others
Aug 6 (Reuters) - Allergan, which is selling its generics business to focus on branded ***** and aesthetics products, aims to acquire or license products that have already shown promise in studies, and leave the riskier discovery process to small biotechs and academic researchers.


http://rc.feedsportal.com/r/23456674...28/rc/1/rc.img

http://rc.feedsportal.com/r/23456674...28/rc/2/rc.img

http://rc.feedsportal.com/r/23456674...28/rc/3/rc.img

http://da.feedsportal.com/r/23456674...9/sc/28/a2.img
http://adchoice.feedsportal.com/r/23.../sc/28/ach.imghttp://pi.feedsportal.com/r/23456674.../sc/28/a2t.imghttp://pi2.feedsportal.com/r/2345667...sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...qQ:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...qQ:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/maI0S2V9Sr0